Improvement of metabolic syndrome by irbesartan via the PPARγ/HGF pathway in apolipoprotein E knockout mice.

about

Suppressive effects of irbesartan on inflammation and apoptosis in atherosclerotic plaques of apoE-/- mice: molecular imaging with 14C-FDG and 99mTc-annexin A5.Fimasartan Ameliorates Nonalcoholic Fatty Liver Disease through PPARδ Regulation in Hyperlipidemic and Hypertensive Conditions.

P2860

Q31152104-5605B30C-5385-44F2-A028-1C1B2947B34C Q37721436-046B251F-6AF2-466D-A8AB-828D5EF02919

P2860

Improvement of metabolic syndrome by irbesartan via the PPARγ/HGF pathway in apolipoprotein E knockout mice.

Item

http://www.wikidata.org/entity/Q38300981

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Improvement of metabolic syndr ...... polipoprotein E knockout mice.

@en

type

Item

label

Improvement of metabolic syndr ...... polipoprotein E knockout mice.

@en

prefLabel

Improvement of metabolic syndr ...... polipoprotein E knockout mice.

@en

P1476

Improvement of metabolic syndr ...... polipoprotein E knockout mice.

@en

P2093

Amarnath Chatterjee

http://www.w3.org/2001/XMLSchema#string

Hiroshi Kusunoki

http://www.w3.org/2001/XMLSchema#string

Ryuichi Morishita

http://www.w3.org/2001/XMLSchema#string

Yoshiaki Taniyama

http://www.w3.org/2001/XMLSchema#string

P2860

The discovery of hepatocyte growth factor (HGF) and its significance for cell biology, life sciences and clinical medicine

International union of pharmacology. XXIII. The angiotensin II receptors

An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma)

Identification of telmisartan as a unique angiotensin II receptor antagonist with selective PPARgamma-modulating activity.

PPARgamma : a nuclear regulator of metabolism, differentiation, and cell growth.

PPAR(gamma) and glucose homeostasis.

hepatocyte growth factor is a downstream effector that mediates the antifibrotic action of peroxisome proliferator-activated receptor-gamma agonists.

Effect of the angiotensin receptor blocker irbesartan on metabolic parameters in clinical practice: the DO-IT prospective observational study.

NASH and atherosclerosis are two aspects of a shared disease: central role for macrophages.

Therapeutic effects of angiotensin II type 1 receptor blocker, irbesartan, on non-alcoholic steatohepatitis using FLS-ob/ob male mice.

P304

65-70

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/BR.2012.28

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Hiromi Rakugi

P577

2012-10-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24648895

http://www.w3.org/2001/XMLSchema#string

P921

knockout mouse

metabolic syndrome

P932

3956680

http://www.w3.org/2001/XMLSchema#string

Improvement of metabolic syndrome by irbesartan via the PPARγ/HGF pathway in apolipoprotein E knockout mice.

about

P2860

P2860

Improvement of metabolic syndrome by irbesartan via the PPARγ/HGF pathway in apolipoprotein E knockout mice.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932